• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局限性哑铃型神经母细胞瘤:一项对1982年至1987年间采用相同方案治疗的25例病例的研究。

Localized dumbbell neuroblastoma: a study of 25 cases treated between 1982 and 1987 using the same protocol.

作者信息

Plantaz D, Hartmann O, Kalifa C, Sainte-Rose C, Lemoine G, Lemerle J

机构信息

Department of Pediatrics, Institut Gustave Roussy, Villejuif, France.

出版信息

Med Pediatr Oncol. 1993;21(4):249-53. doi: 10.1002/mpo.2950210403.

DOI:10.1002/mpo.2950210403
PMID:8469218
Abstract

Among the 108 non-metastatic neuroblastomas treated at the Institut Gustave Roussy between 1982 and 1987, 25 dumbbell neuroblastomas were observed. Therapeutics included: 1) an initial laminectomy in forms with neurological deficit; 2) surgical excision of the primary tumor; 3) preoperative chemotherapy in children in which the primary tumor was considered as unresectable at diagnosis and postoperative chemotherapy in cases of incomplete resection; and 4) radiation therapy on macroscopic residual disease. Fifteen out of 25 (60%) presented a neurological deficit. A laminectomy was performed in 14 cases. Neurological recovery was good in 4 cases, partial in 4 cases, and absent in 4 cases. Two patients were worse after the procedure. The event-free survival was 88%. This high survival rate is linked: 1) to the non-metastatic stage; 2) to a high proportion of children under 1 year of age (18/25) (median age = 7 months); and 3) to a high proportion of thoracic location (12/25). The high incidence of macroscopically incomplete excision (13/25) did not jeopardize the prognosis. Out of the 22 survivors, there were 8 cases of major neurological sequellae (36%) and 5 cases of major orthopedic ones (26%). The coexistence of a serious functional prognosis and an excellent vital prognosis for these patients has led us to analyse the therapeutic modalities, to reevaluate the necessity of routine initial neurosurgical removal by laminectomy and to discuss the use of first line chemotherapy.

摘要

1982年至1987年间,古斯塔夫·鲁西研究所共治疗了108例非转移性神经母细胞瘤,其中观察到25例哑铃状神经母细胞瘤。治疗方法包括:1)对有神经功能缺损的患者先行椎板切除术;2)手术切除原发肿瘤;3)对诊断时认为无法切除原发肿瘤的儿童进行术前化疗,对切除不完全的病例进行术后化疗;4)对肉眼可见的残留病灶进行放射治疗。25例中有15例(60%)出现神经功能缺损。14例行椎板切除术。4例神经功能恢复良好,4例部分恢复,4例未恢复。2例术后病情恶化。无事件生存率为88%。这种高生存率与以下因素有关:1)处于非转移阶段;2)1岁以下儿童比例高(18/25)(中位年龄=7个月);3)胸段位置比例高(12/25)。肉眼切除不完全的发生率高(13/25)并未影响预后。在22名幸存者中,有8例出现严重神经后遗症(36%),5例出现严重骨科后遗症(26%)。这些患者严重功能预后与良好生存预后并存,促使我们分析治疗方式,重新评估常规先行椎板切除术进行神经外科切除的必要性,并讨论一线化疗的使用。

相似文献

1
Localized dumbbell neuroblastoma: a study of 25 cases treated between 1982 and 1987 using the same protocol.局限性哑铃型神经母细胞瘤:一项对1982年至1987年间采用相同方案治疗的25例病例的研究。
Med Pediatr Oncol. 1993;21(4):249-53. doi: 10.1002/mpo.2950210403.
2
[Dumbbell neuroblastoma. Experience at the Gustave Roussy Institute in 38 cases treated from 1982 to 1987].
Arch Fr Pediatr. 1991 Oct;48(8):529-33.
3
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.N-Myc基因扩增是局限性神经母细胞瘤的主要预后因素:法国NBL 90研究结果。法国儿科肿瘤学会神经母细胞瘤研究组。
J Clin Oncol. 1997 Mar;15(3):1171-82. doi: 10.1200/JCO.1997.15.3.1171.
4
Nonmetastatic thoracic neuroblastomas: a review of 40 cases.非转移性胸段神经母细胞瘤:40例病例回顾
Med Pediatr Oncol. 1991;19(4):253-7. doi: 10.1002/mpo.2950190408.
5
Postoperative treatment of nonmetastatic visible residual neuroblastoma: a Pediatric Oncology Group study.非转移性可见残留神经母细胞瘤的术后治疗:一项儿科肿瘤学组的研究。
J Clin Oncol. 1991 Jul;9(7):1181-8. doi: 10.1200/JCO.1991.9.7.1181.
6
[Neuroblastomas treated at the Gustave-Roussy Institute from 1975 to 1979. 173 cases].[1975年至1979年在古斯塔夫-鲁西研究所治疗的神经母细胞瘤。173例]
Arch Fr Pediatr. 1983 Jan;40(1):15-21.
7
Pelvic neuroblastoma: low mortality and high morbidity.盆腔神经母细胞瘤:低死亡率和高发病率。
J Pediatr Surg. 2000 May;35(5):724-8. doi: 10.1053/jpsu.2000.6076.
8
The Clinical Management and Outcomes of Pelvic Neuroblastic Tumors.盆腔神经母细胞瘤的临床管理和预后。
J Surg Res. 2020 May;249:8-12. doi: 10.1016/j.jss.2019.12.009. Epub 2020 Jan 7.
9
[Evaluation of efficacy of treatment for 30 children with neuroblastoma].[30例神经母细胞瘤患儿的治疗疗效评估]
Ai Zheng. 2003 Dec;22(12):1343-5.
10
Neuroblastoma: an assessment of therapy in reference to staging.神经母细胞瘤:参照分期的治疗评估
J Pediatr Surg. 1971 Oct;6(5):595-600. doi: 10.1016/0022-3468(71)90384-8.

引用本文的文献

1
Spontaneous regression of intraspinal neuroblastoma.
Pediatr Surg Int. 1997 Apr;12(4):305-7. doi: 10.1007/BF01372157.
2
Pelvic neuroblastoma--implications for a new favorable subgroup: a Children's Cancer Group experience.盆腔神经母细胞瘤——对一个新的预后良好亚组的启示:儿童癌症研究组的经验
Ann Surg Oncol. 1995 Nov;2(6):516-23. doi: 10.1007/BF02307085.